Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period. The global OTC drugs market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of market during the forecast period. The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of market over the next few years.

The global over the counter (OTC) drugs market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other. Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases. The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population. Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form. Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.

Major players operating in the global over the counter (OTC) drugs market include Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of global over the counter (OTC) drugs market from 2015 to 2018.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global over the counter (OTC) drugs market based on product, dosage form, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To conduct pricing analysis for global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Over the Counter (OTC) Drugs Market, By Product:
    • Cough, Cold, and Flu, Analgesics
    • Dermatology Products
    • Vitamins, Mineral, and Supplements (VMS)
    • Other
  • Global Over the Counter (OTC) Drugs Market, By Dosage Form:
    • Tablets
    • Capsules
    • Powders
    • Ointments
    • Liquids
  • Global Over the Counter (OTC) Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacy
    • Other
  • Global Over the Counter (OTC) Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Over the Counter (OTC) Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)

6.2.2.     By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)

6.2.3.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)

6.2.4.     By Company (2019)

6.2.5.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Dosage Form

7.2.3.     By Distribution Channel

7.2.4.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Over the Counter (OTC) Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Dosage Form

7.3.1.2.3.             By Distribution Channel

7.3.2.     India Over the Counter (OTC) Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Dosage Form

7.3.2.2.3.             By Distribution Channel

7.3.3.     Australia Over the Counter (OTC) Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Dosage Form

7.3.3.2.3.             By Distribution Channel

7.3.4.     Japan Over the Counter (OTC) Drugs Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Dosage Form

7.3.4.2.3.             By Distribution Channel

7.3.5.     South Korea Over the Counter (OTC) Drugs Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Dosage Form

7.3.5.2.3.             By Distribution Channel

8.    Europe Over the Counter (OTC) Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Dosage Form

8.2.3.     By Distribution Channel

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Over the Counter (OTC) Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Dosage Form

8.3.1.2.3.             By Distribution Channel

8.3.2.     Germany Over the Counter (OTC) Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Dosage Form

8.3.2.2.3.             By Distribution Channel

8.3.3.     United Kingdom Over the Counter (OTC) Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Dosage Form

8.3.3.2.3.             By Distribution Channel

8.3.4.     Italy Over the Counter (OTC) Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Dosage Form

8.3.4.2.3.             By Distribution Channel

8.3.5.     Spain Over the Counter (OTC) Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Dosage Form

8.3.5.2.3.             By Distribution Channel

9.    North America Over the Counter (OTC) Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Dosage Form

9.2.3.     By Distribution Channel

9.2.4.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Over the Counter (OTC) Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Dosage Form

9.3.1.2.3.             By Distribution Channel

9.3.2.     Mexico Over the Counter (OTC) Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Dosage Form

9.3.2.2.3.             By Distribution Channel

9.3.3.     Canada Over the Counter (OTC) Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Dosage Form

9.3.3.2.3.             By Distribution Channel

10.  South America Over the Counter (OTC) Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Dosage Form

10.2.3.  By Distribution Channel

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Over the Counter (OTC) Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Dosage Form

10.3.1.2.3.           By Distribution Channel

10.3.2.  Argentina Over the Counter (OTC) Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Dosage Form

10.3.2.2.3.           By Distribution Channel

10.3.3.  Colombia Over the Counter (OTC) Drugs Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Dosage Form

10.3.3.2.3.           By Distribution Channel

11.  Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Dosage Form

11.2.3.  By Distribution Channel

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Over the Counter (OTC) Drugs Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Dosage Form

11.3.1.2.3.           By Distribution Channel

11.3.2.  Saudi Arabia Over the Counter (OTC) Drugs Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Dosage Form

11.3.2.2.3.           By Distribution Channel

11.3.3.  UAE Over the Counter (OTC) Drugs Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Dosage Form

11.3.3.2.3.           By Distribution Channel

11.3.4.  Kuwait Over the Counter (OTC) Drugs Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Product

11.3.4.2.2.           By Dosage Form

11.3.4.2.3.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.3.              Leading Players Profiled

14.3.1.  Johnson and Johnson

14.3.2.  GlaxoSmithKline PLC (GSK Consumer Healthcare)

14.3.3.  Perrigo Company PLC

14.3.4.  Reckitt Benckiser Group PLC

14.3.5.  Takeda Pharmaceutical Company Ltd

14.3.6.  Roche Holding AG

14.3.7.  The Procter & Gamble Company

14.3.8.  Sanofi S.A

14.3.9.  Gilead Sciences Inc.

14.3.10.                Bayer Healthcare AG

14.3.11.                AstraZeneca plc.

14.3.12.                Alacer Corp.

14.3.13.                Alcon Inc.

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com
  • Figure 1: Global OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 2: Global OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 3: Global OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 4: Global OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 5: Global OTC Drugs Market Size, By Company (USD Million), 2015-2025F

    Figure 6: Global OTC Drugs Market Size, By Region (USD Million), 2015-2025F

    Figure 7: Global OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 8: North America OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 9: North America OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 10: North America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 11: North America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 12: North America OTC Drugs Market Size, By Country (USD Million), 2015-2025F

    Figure 13: North America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F

    Figure 14: North America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 15: United States OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 16: United States OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 17: United States OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 18: United States OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 19: United States OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 20: Canada OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 21: Canada OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 22: Canada OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 23: Canada OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 24: Canada OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 25: Mexico OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 26: Mexico OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 27: Mexico OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 28: Mexico OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 29: Mexico OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 30: Europe OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 31: Europe OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 32: Europe OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 33: Europe OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 34: Europe OTC Drugs Market Size, By Country (USD Million), 2015-2025F

    Figure 35: Europe OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F

    Figure 36: Europe OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 37: France OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 38: France OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 39: France OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 40: France OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 41: France OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 42: Germany OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 43: Germany OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 44: Germany OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 45: Germany OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 46: Germany OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 47: Italy OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 48: Italy OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 49: Italy OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 50: Italy OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 51: Italy OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 52: Spain OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 53: Spain OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 54: Spain OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 55: Spain OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 56: Spain OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 57: United Kingdom OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 58: United Kingdom OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 59: United Kingdom OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 60: United Kingdom OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 61: United Kingdom OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 62: Asia-Pacific OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 63: Asia-Pacific OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 64: Asia-Pacific OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 65: Asia-Pacific OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 66: Asia-Pacific OTC Drugs Market Size, By Country (USD Million), 2015-2025F

    Figure 67: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F

    Figure 68: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 69: China OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 70: China OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 71: China OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 72: China OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 73: China OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 74: India OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 75: India OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 76: India OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 77: India OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 78: India OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 79: Japan OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 80: Japan OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 81: Japan OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 82: Japan OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 83: Japan OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 84: South Korea OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 85: South Korea OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 86: South Korea OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 87: South Korea OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 88: South Korea OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 89: Australia OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 90: Australia OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 91: Australia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 92: Australia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 93: Australia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 94: Middle East and Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 95: Middle East and Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 96: Middle East and Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 97: Middle East and Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 98: Middle East and Africa OTC Drugs Market Size, By Country (USD Million), 2015-2025F

    Figure 99: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F

    Figure 100: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 101: South Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 102: South Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 103: South Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 104: South Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 105: South Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 106: Saudi Arabia OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 107: Saudi Arabia OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 108: Saudi Arabia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 109: Saudi Arabia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 110: Saudi Arabia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 111: Kuwait OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 112: Kuwait OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 113: Kuwait OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 114: Kuwait OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 115: Kuwait OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 116: UAE OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 117: UAE OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 118: UAE OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 119: UAE OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 120: UAE OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 121: South America OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 122: South America OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 123: South America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 124: South America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 125: South America OTC Drugs Market Size, By Country (USD Million), 2015-2025F

    Figure 126: South America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F

    Figure 127: South America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 128: Brazil OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 129: Brazil OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 130: Brazil OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 131: Brazil OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 132: Brazil OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 133: Argentina OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 134: Argentina OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 135: Argentina OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 136: Argentina OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 137: Argentina OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

    Figure 138: Colombia OTC Drugs Market Size, By Value (USD Million), 2015-2025F

    Figure 139: Colombia OTC Drugs Market Size, By Product (USD Million), 2015-2025F

    Figure 140: Colombia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F

    Figure 141: Colombia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F

    Figure 142: Colombia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F